Technical Analysis for HIK - Hikma Pharmaceuticals Plc

Grade Last Price % Change Price Change
D 2350.0 1.16% 27.00
HIK closed up 1.16 percent on Friday, May 7, 2021, on 74 percent of normal volume.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Up Flat
Historical HIK trend table...

Date Alert Name Type % Chg
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Inside Day Range Contraction 0.00%
50 DMA Support Bullish 1.16%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 1.16%
Down 3 Days in a Row Weakness 1.16%
Lower Bollinger Band Touch Weakness 1.16%
BB Squeeze Ended Range Expansion 0.56%
200 DMA Resistance Bearish -0.42%
Bearish Engulfing Bearish -0.42%
Fell Below 20 DMA Bearish -0.42%
Older End-of-Day Signals for HIK ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Hikma Pharmaceuticals Plc Description

Hikma Pharmaceuticals Plc is a pharmaceutical company. The Company develops, manufactures and markets a range of branded and non-branded generic pharmaceutical products in solid, semi-solid, liquid and injectable final dosage forms, across the United States, the Middle East and North Africa (MENA) region and Europe. The Company's segments include Branded, Injectables, Generics and Others. The Branded business sells branded generics and in-licensed products across the MENA region and other markets. The Injectables business sells specialized generic injectable products across the globe. The Generics business sells non-injectable generic products in the United States. The Branded business has approximately 380 products in over 1,120 dosage forms and strengths. Its products include Amoclan, Blopress, Omnicef, Prograf and Suprax. The Injectables business' products include Argatroban, Fentanyl, Glycopyrrolate, Nicardipine and Phenylephrine.


Classification

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Pharmaceutical Pharmaceuticals Strength North Africa Pharmaceutical Products Pharmaceutical Companies Supra Dosage Forms

Is HIK a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 2768.0
52 Week Low 2086.4875
Average Volume 433,517
200-Day Moving Average 2446.96
50-Day Moving Average 2308.18
20-Day Moving Average 2384.55
10-Day Moving Average 2358.00
Average True Range 55.78
ADX 17.95
+DI 26.17
-DI 23.95
Chandelier Exit (Long, 3 ATRs ) 2309.66
Chandelier Exit (Short, 3 ATRs ) 2462.34
Upper Bollinger Band 2466.37
Lower Bollinger Band 2302.73
Percent B (%b) 0.29
BandWidth 6.86
MACD Line 6.26
MACD Signal Line 15.71
MACD Histogram -9.4467
Fundamentals Value
Market Cap 5.42 Billion
Num Shares 230 Million
EPS 211.10
Price-to-Earnings (P/E) Ratio 11.13
Price-to-Sales 3.67
Price-to-Book 4.22
PEG Ratio 2.60
Dividend 0.24
Dividend Yield 0.01%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2399.50
Resistance 3 (R3) 2394.00 2372.00 2391.25
Resistance 2 (R2) 2372.00 2359.39 2374.75 2388.50
Resistance 1 (R1) 2361.00 2351.61 2366.50 2366.50 2385.75
Pivot Point 2339.00 2339.00 2341.75 2341.75 2339.00
Support 1 (S1) 2328.00 2326.39 2333.50 2333.50 2314.25
Support 2 (S2) 2306.00 2318.61 2308.75 2311.50
Support 3 (S3) 2295.00 2306.00 2308.75
Support 4 (S4) 2300.50